Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy.

Nat Commun · 2023 · PMC10090190 · PMID 37041154

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a negative trendno p-value reported

In contrast, a negative trend was appreciated between the expression of STEAP1 and SYP (Supplementary Fig. 2c ).

also in 2,482 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.